 |
Previous Article | Next Article 
The Journal of Neuroscience, November 1, 1999, 19(21):9412-9425
Unilateral GluR2(B) Hippocampal Knockdown: A Novel Partial
Seizure Model in the Developing Rat
Linda K.
Friedman1, 2 and
Alexei R.
Koudinov3
1 Department of Neuroscience, Seton Hall University,
South Orange, New Jersey 07079, Department of
Neuroscience, New Jersey Neuroscience Institute, Edison, New Jersey,
2 Albert Einstein College of Medicine, Bronx, New York,
and 3 Department of Neurobiology, Weizmann Institute,
Rehovot, Israel
 |
ABSTRACT |
Kainic acid (KA) induces status epilepticus in both adult and young
rats but with different consequences on pathology and gene expression.
In adults, GluR2(B) AMPA subunit expression is markedly reduced in CA3
neurons before neurodegeneration. In pups, the GluR2(B) subunit is
sustained, possibly contributing to neuronal survival. Mechanisms
underlying the reduced vulnerability of developing neurons to seizures
was investigated by examining the effects of unilateral microinfusions
of GluR2(B) antisense oligodeoxynucleotides (AS-ODNs) into the
hippocampus of young rats in the presence or absence of a subconvulsive
dose of KA. GluR2(B) AS-ODN infusions resulted in spontaneous
seizure-like behavior, high stimulus intensity population spikes in the
absence of long-term potentiation, and neurodegeneration of CA3 neurons
lateral to the infusion site. Electroencephalography revealed
paroxysmal activity and high-frequency high-amplitude discharges
associated with vigorous and continuous scratching, wild running, or
bilateral jerking movements. Pups lacking phenotypic behavior exhibited
high-rhythmic oscillations and status epilepticus by the dose of KA
used. Radiolabeled AS-ODNs accumulated throughout the ipsilateral
dorsal hippocampus. GluR2(B) but not GluR1(A) receptor protein was
markedly reduced after GluR2(B) knockdown. In contrast, GluR1(A)
knockdown reduced GluR1(A) but not GluR2(B) protein without change in
behavior or morphology. Therefore, unilateral downregulation of
hippocampal GluR2(B) but not GluR1(A) protein reduces the seizure
threshold and survival of CA3 neurons in the immature hippocampus,
possibly providing a novel partial seizure model in the developing rat.
Key words:
epilepsy; development; GluR2(B); knockdown; hippocampus; neurodegeneration
 |
INTRODUCTION |
Human temporal lobe epilepsy is
associated with marked neurodegeneration of the hippocampus (Babb and
Brown, 1987 ; Bruton, 1988 ). Sustained Ca2+
influx through glutamate receptor channels may influence delayed seizure-induced damage (Siesjo and Bengtsson, 1989 ; Choi, 1990 ; Dingledine et al., 1990 ). AMPA-type glutamate receptors lacking the
GluR2(B) subunit are highly Ca2+
permeable, whereas heteromeric assemblies containing the GluR2(B) subunit are relatively impermeable to Ca2+
(Hollman et al., 1991 ; Verdoorn et al., 1991 ; Burnashev et al., 1992 )
and may be involved in the seizure-induced damage and glutamate toxicity (the "GluR2(B) hypothesis") (Pollard et al., 1993 ;
Friedman et al., 1994 ; 1997 ; Friedman, 1998 ).
In adult rats, kainic acid (KA)-induced status epilepticus results in a
marked but nonuniform reduction of GluR2(B) mRNA (Pollard et al., 1993 ;
Friedman et al., 1994 ) and protein (Friedman, 1998 ) within vulnerable
CA3 neurons at times preceding significant cell loss. Similar
downregulations are observed in limbic structures after amygdala
kindling (Prince et al., 1995 ) or in resected CA3 (Lynd-Balta et al.,
1996 ; Mathern et al., 1998 ) and neocortex (DeFelipe et al.,
1994 ) of human patients with temporal lobe epilepsy. In young rats,
which are highly prone to seizures but resistant to KA seizure-induced
brain damage (Cherubini et al., 1983 ; Albala et al., 1984 ; Nitecka et
al., 1984 ; Holmes and Thompson, 1988 ; Wonziak et al., 1991 ; Friedman et
al., 1997a ,b ), GluR2(B) hippocampal mRNA and protein expression
remain constant and may contribute to neuronal survival (Friedman et
al., 1997a ). The functional role of
Ca2+ influx through AMPA receptors at the
physiological level has been unclear, but it is now known that
different levels of GluR2(B) gene expression can result in a number of
neurological deficits and age-dependent CA3 vulnerability (Brusa et
al., 1995 ; Feldmeyer et al., 1999 ). In keeping with this, we
found that hippocampal GluR2(B) antisense knockdown results in
seizure-like behavior and CA3 neurosclerosis during a specific
postnatal period (third week) (Friedman and Velísková,
1998 ). In contrast, adult GluR2(B) knockout mutants show no obvious
alterations in hippocampal morphology or electroencephalography (EEG)
activity, although during the third postnatal week they display reduced
body weight, increased mortality, and enhancement of long-term
potentiation (LTP) (Jia et al., 1996 ). Together, GluR2(B) antisense and
genetic findings demonstrate that expression of the edited GluR2(B)
subunit is essential during a particular stage in development to
prevent occurrence of limbic seizures, maintain hippocampal plasticity, and contribute to CA3 neuronal survival.
Regulation of the GluR2(B) subunit with phosphodiesterized antisense
oligodeoxynucleotides (AS-ODNs) allows one to examine possible roles of
AMPA receptor subunits within a specific brain region and age. It is
possible that regulation of the GluR2(B) gene after severe seizures may
influence transcriptional factors or result in post-translational
modifications that may trigger cell death genes (Schreiber and Baudry,
1995 ; Charriaut-Marlangue et al., 1996 ). The present study identifies
molecular, cellular, and physiological consequences of modifying
AMPA-mediated Ca2+ permeability during the
third postnatal week to directly test the GluR2(B) hypothesis.
Developmental aspects are emphasized because both antisense and genetic
approaches reveal age-specific epileptogenesis and selective CA3
hippocampal neurodegeneration at a time when the brain has a high
propensity toward seizures but is relatively resistant to
seizure-induced damage.
 |
MATERIALS AND METHODS |
Unilateral intracranial cannula/bipolar electrode
implantation and ODN administration. Sprague Dawley male albino
pups [postnatal day 13 (P13), 25-30 gm; n = 74] were
kept on a 12 hr light/dark cycle at room temperature (55% humidity).
Rat pups were anesthetized intraperitoneally with a mixture of 70 mg/kg
ketamine and 6 mg/kg of xylazine and then stereotaxically implanted
with either chronic guide (25-G) cannulae or cannula/bipolar electrode
assemblies into the right hippocampus to administer ODNs and obtain
ipsilateral hippocampal EEG recordings (coordinates in millimeters with
respect to bregma of P13 pups: anteroposterior, 3.2; lateral, 2.4;
dorsal, 2.4; incisor bar at 3.5) (Paxinos and Watson, 1986 ). The
cannulae were angled at 0° from the vertical sagittal plane. After
surgery, young rats were kept in a box under a lamp and then returned
to their lactating mother. Pups recovered from anesthesia and became active 1-3 hr after the surgery. Animals were infused with GluR2(B) AS-ODNs to selectively decrease the hippocampal synthesis of the GluR2(B) subunit as previously described (Friedman and
Velísková, 1998 ). The infusion cannula was force-fitted
onto Teflon tubing attached to a Hamilton syringe. Infusions of Tris
buffer, antisense (AS), sense (S), or missense (NS, scrambled) ODNs
[GluR2(B) AS-ODN, n = 32; GluR2(B) S-ODN,
n = 16; NS-ODN, n = 9; Tris buffer,
n = 2; GluR1(A) AS-ODN, n = 8; GluR1(A)
S-ODN, n = 4] were initiated ~3-4 hr after recovery
from the anesthesia twice daily (9:00-10:00 A.M. and
5:00-6:00 P.M.). A phosphorothiolated 21 mer was designed from base
pairs 30-50, near the initiation codon start site to selectively
decrease the hippocampal synthesis of the GluR1(A) subunit:
5'-CGGTTTTCTAGGTGCGGTTGT-3'. This sequence was effective and not
identical with other mammalian sequences as determined by a search of
the GeneBank/European Molecular Biology Laboratory database. The
sequence of the GluR1(A) S-ODN was (5'-ACAACCGCACCTAGAAAACCG-3'). Rat
pups were killed 24 hr after 4 d of treatment. The injection volume (0.25 µl of 4 µg/µl dissolved in 0.1 mM Tris, pH 7.4) was delivered over 2 min to
reduce spread of the ODNs. In three rats, 33P-radiolabeled GluR2(B) AS-ODNs were
also infused to determine the extent of ODN spread and accumulation.
Behavior was monitored daily between 10:00-3:00 P.M. and 4:00-8:00
P.M. for behavioral changes.
33P autoradiography. To determine that the
ipsilateral dorsal hippocampus was selectively labeled by the infusion
paradigm used, the GluR2(B) AS-ODNs were 5' end-labeled with
[33P] -ATP for 30 min at 37°C,
using a DuPont/NEN oligonucleotide 5' end-labeling system. Labeled
probes were purified on NENSORB20 nucleic acid purification cartridges,
lyophilized, and resuspended in a small volume (10 µl, 1-10 ng/µl)
for microinfusion into the hippocampus. Approximately 1 µCi of
33P-labeled GluR2(B) AS-ODNs was
microinfused twice daily into the hippocampus, and
33P autoradiography was performed after
4 d of exposure to the radiolabeled GluR2(B) AS-ODNs. Brains were
removed and quick-frozen, and serial coronal sections (20 µm) were
cut in a cryostat at 18°C. Sections were mounted and air-dried onto
double-gelatinized slides, then dried overnight in a vacuum desiccator
in the presence of silica crystals. Slides were apposed to x-ray film
for 4 d at 70°C to generate the
33P autoradiographs. Films were scanned
with a CCD camera attached to a Macintosh computer (Quadra 840V).
Optical density measurements of hippocampal accumulations of
33P-labeled ODNs, detected throughout the
dorsal hippocampus, were analyzed with NIH image software to estimate
the extent of ODN spread and accumulation. Optical density readings
were not statistically analyzed because of the small number of pups
injected with radioactivity (n = 3).
EEG recordings and statistical analysis of duration and number of
scratching events. To determine whether behavioral manifestations corresponded to changes in electrographic activity, EEG recordings were
obtained from a subset of rat pups that received the GluR2(B) AS-ODN
sequence [GluR2(B) AS-ODNs, n = 9; S-ODNs,
n = 5; and NS-ODNs, n = 5] [GluR2(B)
AS-ODNs, n = 4] for at least 30-60 min twice daily. EEG recordings were also obtained from a separate group of rat
pups that received a low, subconvulsive dose of KA acid (2.0 mg/kg)
administered intraperitoneally (n = 5), after cannula implantation and 4 d of S-ODN infusions to compare
chemoconvulsant-induced automatisms (e.g., scratching) with spontaneous
automatisms arising in pups treated only with GluR2(B) AS-ODNs.
Duration and number of scratching events were quantified from animals
in the presence and absence of KA after antisense and control sequence
treatments. Other manifestations have been reported (Friedman and
Velísková, 1998 ). The data were compared by one-way
ANOVA with post hoc Fischer protected least
significant difference test (ANOVA). Duration of scratching
events was measured only from EEG recording traces, for accuracy. In
another subgroup of GluR2(B) AS-ODN-treated rat pups (n = 6), the progression of scratching was assessed and evaluated by the
Student's paired t test. The level of significance was preset to p < 0.05.
Ex vivo hippocampal slice physiology of deprived GluR2(B)
circuitry. For CA1 hippocampal slice recordings, 13-d-old Wistar rats were raised in our local departmental animal facility in Rehovot.
Experiments were performed in three types of control animals: (1)
littermate no treatment, (2) S-ODN treatment, or (3) slices prepared
from the contralateral hemisphere. After 4 d of intrahippocampal
GluR2(B) AS-ODN infusions, brains were rapidly removed and placed into
cold (2-4°C) artificial CSF (ACSF), pH 7.4, containing (in
mM): 124 NaCl, 2.0 KCl, 1.24 KH2PO4, 2.0 MgSO4, 2.5 CaCl2, 26 NaHCO3, and 10 D-glucose) saturated
with 95% O2/5% CO2 gas
mixture (flow rate 0.4 l/min) and adjusted with sucrose to 320 mOsm
osmolarity as described previously (Auerbach and Segal, 1997 ; Koudinov
et al., 1998 ). Hippocampal slices (400 µm) were prepared with a
McIlwain tissue slicer. After incubation in a recreation chamber at
room temperature for 1.5 hr in ACSF, slices were immediately
transferred to a recording chamber held at constant temperature
(32°C). Slices were submerged and superfused with ACSF at a flow rate
of 1.8-2.0 ml/min. GluR2(B) knockdown and control slices were tested
sequentially in random order. One extracellular electrode (~4 M ,
0.75 mM NaCl) was guided centrally into stratum radiatum of
CA1 (200 µm deep) near the infusion site with a Nikon binocular
system (4× objective) to obtain two channel measurements of field
EPSP (fEPSP) recordings. Two stimulating electrodes (bipolar stainless steel) were placed into CA1 stratum radiatum, either near the
infusion site or distally toward the CA2 region, and then stimulated
from either of the two sites. Stimulations were delivered every 30 sec
for each channel at 50 µsec pulse duration with a 15 sec time
interval between the channels. Stimulus intensity was adjusted so that
initial baseline evoked responses (~0.8 mV) were approximately
one-half of the maximum possible (~1.6 mV), and 2-6 mA stimulation
intensities were used for input/output curve generation. After stable
baseline recordings were established, tetanic LTP (tLTP) was induced by
delivering a 100 Hz, 1 sec train through the stimulation electrode at
the test baseline stimulus intensity (Koudinov et al., 1998 ). Data were
collected, stored, and analyzed on an IBM-compatible computer using
Asyst 3.1 data acquisition and analysis software. fEPSPs recorded from
a single site in response to alternately delivered stimuli to two
separate inputs in control versus experimental slices were averaged
from both pathways (three to five hippocampal slices per animal).
Values from control slices were similar whether recorded from
contralateral hippocampus, sham, or sense-infused pups and therefore
averaged. Values from slices obtained from pups with seizure behavior
were also similar in both pathways and therefore averaged. In slices (n = 4) from an animal that did not exhibit seizures,
there were differences in the two stimulation pathways; therefore these
data were averaged separately. All data were normalized with respect to
the steady baseline values and expressed as mean ± SEM.
Nonparametric unpaired Mann-Whitney test was used for determining
significant differences between potentiation levels of control and
GluR2(B) knockdown slices at the indicated times. A probability of
p < 0.05 or less was accepted as statistically significant.
Histology. To elucidate direct effects of the cannulae
versus GluR2(B) knockdown-induced injury in the hippocampus, Nissl (thionin) or chromatin (hematoxylin/eosin) histological stains were
used on serial sections (20-30 µm), cut from a cryostat, to examine
cell loss and alterations in morphology. Approximately 30 slides were
prepared from animals that were not processed for immunocytochemistry.
Three or four sections were mounted per slide from an anterior to
posterior direction so that each slide contained sections from several
hippocampal levels. Every fourth or fifth slide was stained with
thionin to evaluate cell loss at anterior and posterior levels, and
hematoxylin/eosin was used on remaining sections to detect subtle
histopathology (e.g., eosinophilia) throughout the hippocampus.
Approximately six alternate sections were collected for histology from
pups processed for immunolabeling studies. Cannula placement or
disruption of hippocampal tissue produced by the S/NS-ODN control
sequence administration was measured and distinguished under light
microscopy, from the distant neurodegeneration of the CA3a region after
appearance of seizure behavior by the GluR2(B) AS-ODNs.
In situ hybridization. In situ hybridization
for AMPA and NR1 mRNA detection was used as described (Friedman et al.,
1994 ) to determine whether GluR2(B) mRNA levels were stable in response to the AS-ODN treatment (at 24 hr after the last infusion): GluR2(B) AS-ODNs, n = 5; GluR2(B) S-/NS-ODNs, n = 5). GluR2(B) and NR1 cDNAs were transcribed with
[35S]UTP-labeled RNA and T7 RNA
polymerase. Coronal sections (20 µm, 16°C) from antisense and
S/NS-ODN-treated animals were cut and thaw-mounted on
gelatin/poly-Ml-lysine-coated slides.
Sections were post-fixed with 4% (w/v) paraformaldehyde, acetylated
with acetic anhydride (0.25%), and stored in 95% ethanol at 4°C. On the next day, prehybridization solution (100 µl) was added directly to sections and incubated for 2 hr at 50°C [50% (w/v)
formamide/2.5 × Denhardt's solution/0.6 M
NaCl/10 mM
Tris.HCl/1 mM
EDTA/0.05% SDS/herring sperm DNA (150 µg/ml)/total yeast RNA (50 µg/ml)]. Hybridization solution (100 µl) containing the 35S-labeled riboprobe
(106 cpm/section, 1 ng/µl), 10% (w/v)
dextran sulfate, and 10 mM dithiothreitol was
added overnight (50°C). Adjacent sections from the same rats were
labeled with GluR1(A), GluR2(B), and NR1 probes. The next day, sections
were washed, treated with RNase A (20 µg/ml), washed for 2 hr in
0.2 × SSC at 50°C, and dehydrated in graded ethanols. For
autoradiography, slides were apposed (1-7 d) to Kodak XR5 film. For
cellular resolution, sections were dipped in Kodak NTB-2 emulsion,
developed after 1-2 weeks, counterstained with hematoxylin/eosin, and
examined under a light microscope with phase contrast (Nikon Eclipse 800).
Specificity of mRNA labeling and quantification. Conditions
were of sufficiently high stringency as to rule out cross-hybridization among GluR1(A), GluR2(B), and GluR3 (Friedman et al., 1994 ) and more
distantly related glutamate receptor subunits (GluR5-GluR7, KA1, KA2).
GluR4 expression is prominent only in the cerebellum (Keinänen et
al., 1990 ). GluR1(A), GluR2(B), and GluR3 are "pan" probes (Sommer
et al., 1990 ) in that they label both "flip" and "flop" splice
variants. The NR1 probe shares <20% sequence identity with NR2A-C and
does not cross-react with other NMDA receptor subtypes (Nakanishi et
al., 1992 ). Autoradiographs and emulsion-dipped sections were scanned
with a CCD camera, and densitometric measurements were obtained and
analyzed with NIH image software. Individual grains overlying CA3
neurons were also counted manually with NIH tools. Student's paired
t test was used for statistical analysis, and significance
was set at p < 0.05.
Immunohistochemistry. To examine whether GluR2(B) or
GluR1(A) proteins were selectively downregulated by the GluR2(B) or
GluR1(A) AS-ODN treatment, respectively, immunocytochemistry was
performed with AMPA subunit-specific antibodies in vibratome (40 µm)
sections prepared from AS-ODN-, S-ODN-, or NS-ODN-treated rat pups at
the level of the hippocampus as described (Vissavajjhala et al., 1996 ; Friedman, 1998 ; Friedman and Velísková, 1998 ).
Twenty-four hours after 4 d of GluR2(B) or GluR1(A) AS-ODN
infusions, pups were killed by transcardial perfusion. The
anti-GluR1(A) (0.6 µg/ml) and anti-GluR2(B) (0.6 µg/ml) primary
antibodies were used. Free-floating sections were washed in PBS (two
times), then incubated with 0.5% H202 for 15 min to remove
endogenous peroxides. Sections were then washed (four times for 10 min
each). For the GluR2(B)-specific antibody (6C4), sections were blocked
for 30 min in 5% horse serum/0.5% BSA-PBS. For the polyclonal
antibody, GluR1(A), sections were blocked in 5% goat serum/0.5%
BSA-PBS. Monoclonal and polyclonal primary antibodies were incubated
for 48 hr at 4°C. Tissue sections were washed (three times for 10 min
each) in PBS to remove primary antibodies. Secondary biotinylated goat
anti-mouse or anti-rabbit IgG (H + L, diluted 1:200) were added
for 2 hr at 25°C. After three washes, ABC solution was added
for 1 hr. For visualization, the sections were reacted with 3',
3-diaminobenzidine tetrahydrochloride (10 mg/20 ml and 3 µl hydrogen
peroxide). Sections were then washed, mounted, dehydrated, cleared, and coverslipped.
Controls. To assess immunocytochemical signal specificity,
additional sections were incubated with (1) PBS followed by goat anti-rabbit or horse anti-mouse secondary antibody, (2) preimmune mouse
or rabbit serum at the same dilution as the primary antibody, or (3)
primary antibody, which had been preadsorbed with the peptide antigen,
followed by secondary antibody. All three control conditions gave no
specific labeling.
Drugs and chemicals. Oligodeoxynucleotides were synthesized
by Genosys Biotechnologies (The Woodlands, Texas). Surgical supplies were obtained from Plastic One (Roanoke, VA). Chemicals were bought from commercial sources. GluR1(A) and GluR2(B) cDNAs were generously provided by Dr. P. Seeburg (University of Heidelberg, Germany). The
specific monoclonal antibodies (mAbs) GluR2(B) (6C4) and GluR2(4) (3A11) were generous gifts from Dr. J. Morrison (Mount Sinai Medical Center, NY), and polyclonal GluR1(A) and GluR2(B) antibodies were purchased commercially from Chemicon International (Temecula, CA).
 |
RESULTS |
Anatomical localization of GluR2(B) AS-ODNs by
33P autoradiography
To determine that the ipsilateral dorsal hippocampus was
selectively labeled by the infusion paradigm used, the GluR2(B) AS-ODNs were 5' end-labeled and processed for 33P
autoradiography. Stereotaxic coordinates of the intrahippocampal infusion and recording site are illustrated (Fig.
1A). After 4 d of
knockdown treatment, autoradiographs of full coronal sections revealed
that accumulation and spread of the microinfused ODNs were highly
restricted to the dorsal hippocampus of the ipsilateral hemisphere
(Fig. 1B, a-c). All major subfields were
labeled, whereas other structures, except for small portions of the
dorsal thalamus, were absent in signal or similar to film background
(entire section is illustrated by a schematic outline of the center
section) (Fig. 1B, b). The GluR2(B)
AS-ODNs also did not accumulate in the ventral hippocampus. The
measured distance of the intrahippocampal GluR2(B) AS-ODN spread and
regional accumulation extending from the medial septum to the posterior
region of the dorsal hippocampus was ~2.4-2.8 mm3 (Fig. 1B,
a-c). Optical density measurements (NIH image software) were averaged from medial and lateral portions of the hippocampus around the infusion site at anterior, medial, and posterior levels. GluR2(B) AS-ODN radioactivity formed a mediolateral concentration gradient showing that the highest accumulations occurred in or around
the cannula infusion site within the medial portion of the hippocampus
(Fig. 1B, b, Table
1). The concentration gradient diminished
in posterior sections distant from the point of injection (Fig.
1B, c).

View larger version (23K):
[in this window]
[in a new window]
|
Figure 1.
A, Cannula/bipolar electrode
assembly location is indicated by arrow.
B, Nine entire coronal sections labeled by
33P GluR2(B) AS-ODN autoradiography are on display (as
indicated by outline of center section) from the most
anterior portion of the dorsal hippocampus to the ventral posterior
region. Distance between sections on display is 600-800 µm
(a-c) so that the infused GluR2(B) AS-ODN spread or
regional accumulation was approximately 2.4-2.8 mm3
within the ipsilateral dorsal but not ventral hippocampus. Mediolateral
gradients diminished in posterior sections (B,
c), and ODNs did not spread to the contralateral
hippocampus or to other brain regions (not visible or seen as
white background).
|
|
GluR2(B) knockdown-induced automatisms and
seizure-like behavior
Control rat pups treated with equal volumes of sense (S) or
missense (NS, scrambled) ODN sequences exhibited normal behavior similar to pups that did not undergo surgery or that were infused with
Tris-buffer. Behavior included free movement around the recording chamber with sniffing and washing movements, occasional scratching or
wet dog shakes, or rearing. In control animals infused with vehicle or
S/NS-ODNs, scratching movements were generally short lasting (Fig.
2A, Table
2). In contrast, GluR2(B) knockdown
resulted in altered motor behavior in 80% of the pups receiving
GluR2(B) AS-ODNs; approximately one-half of the animals exhibited
automatisms by 48 hr. Automatisms were characterized by long episodes
of vigorous and continuous scratching (Table 2). This scratching
resembled behavior that occurs in rat pups administered with either low or high doses of KA at similar ages (Cherubini et al., 1983 ; Albala et
al., 1984 ; Tremblay et al., 1984 ). An apparent difference was that the
number of scratching events progressed with time (day 2: 1.03 ± 0.8 vs day 3: 1.68 ± 0.8, n = 6, p < 0.05) in the GluR2(B) AS-ODN
intrahippocampal-infused pups compared with KA control injected pups.
The greatest number of scratching events appeared on day 4. In 40% of
rat pups infused with GluR2(B) AS-ODNs (13 of 32), seizure-like
symptoms progressed. There were jerking and stumbling movements, ball
curling, head nods and shaking, wet dog shakes, or quadrilateral
forelimb jerking movements, with backward jumping and loss of postural
control. Ipsilateral followed by contralateral tremor with wild running
and immobility with forelimb extension occurred in 25% of the GluR2(B)
AS-ODN treated pups. Spontaneous seizure-like behavior often continued
for 30-60 min, stopped, and then reappeared at different times. These
seizure-type behaviors have been quantified and recently reported by us
(Friedman and Velísková, 1998 ). Despite recurring
seizure-like behaviors, GluR2(B) AS-ODN pups fed regularly, so that
weight and mortality were not significantly affected. No seizure-like
behavior was observed in control untreated or S/NS-ODN-treated
groups. Moreover, a separate group of pups was infused unilaterally
with AS-ODNs targeted to the GluR1 subunit. GluR1(A) hippocampal
knockdown did not alter behavior in any of these animals
(n = 8).

View larger version (49K):
[in this window]
[in a new window]
|
Figure 2.
EEG recordings after GluR2(B) knockdown from
ipsilateral pup hippocampus in a freely moving recording chamber.
A, S-ODN (S) baseline EEG with
normal movement artifacts showing a typical short-lasting (<1
sec) scratching event (vertical arrow) (left
portion). B, GluR2(B) AS-ODN-treated pup
(2AS-1) exhibited vigorous and continuous scratching
that produced high-frequency, high-amplitude movement artifacts;
occasional spikes occurred between scratching events (right
portion). C, In another GluR2(B) AS-ODN-treated
pup (2AS-2), convulsive seizure-like behavior including
body tonus with forelimb extension and laying on one side occurred and
was associated with high-frequency low-amplitude rhythmical
activity of increasing size. Large-movement artifacts shown
represent intermittent bilateral jerking movements
(asterisks). D, In GluR2(B)
AS-ODN-treated pups lacking the phenotypic behavior (2AS + KA), a low concentration of KA produced high-frequency
rhythmical oscillations associated with tonic-clonic seizure behavior.
E, In an S-ODN-treated pup (S + KA), a
subconvulsive KA dose produced classic automatisms (e.g., wet dog
shakes, arrowhead) but not the high-frequency rhythmical
oscillations.
|
|
EEG activity after GluR2(B) knockdown in the presence and absence
of KA
Electrographic baseline recordings from control untreated, S-ODN-,
or NS-ODN-treated pups showed normal hippocampal activity and movement
artifacts (Fig. 2A). Low amplitude spikes were
associated with either sleeping or immobility with eyes open (data not
shown). Walking, roaming about the recording chamber, climbing, or
normal short-lasting scratching events produced movement artifacts of high amplitude and low frequency (Fig. 2A, and
quantification in Table 2). The EEG baseline from GluR2(B)
AS-ODN-treated pups before onset of behavioral manifestations was
indistinguishable from that of S/NS-ODN-treated pups. After onset of
seizure-like behavior, the EEG revealed persistent high-frequency
bursts accompanying the long-lasting vigorous scratching episodes.
These produced highly pronounced movement artifacts with occasional
rhythmical spikes that resembled epileptiform activity (Fig.
2B). Wild running followed by forelimb extension and
lying on one side were associated with high-frequency spikes of
increasing amplitude (Fig. 2C, left portion).
There were also high-frequency low-amplitude spikes that correlated
with backward jumping, jerking movements involving all limbs, followed
by loss of postural control and immobility (Fig. 2C). In
other GluR2(B) AS-ODN-infused pups lacking phenotypic expression of
seizure-like behavior, a low, subconvulsant dose of KA (2 mg/kg)
produced high-frequency rhythmical oscillations and behavioral status
epilepticus. These do not occur in rat pups of similar ages treated
with similar doses of KA (Cherubini et al., 1983 ; Albala et al., 1984 ;
Tremblay et al., 1984 ) or in S-ODN-, N-ODN-, or Tris buffer-infused
pups (Fig. 2D). Similarly, control rat pups
pretreated with S-ODNs and followed by injection with KA showed
increased automatisms (i.e., scratching and wet dog shakes) in the
absence of high-frequency rhythmical oscillations (Fig.
2E).
GluR2(B) knockdown produces CA3 cell loss in pups with
seizure behavior
Histology was performed with hematoxylin/eosin or thionin on
serial air-dried coronal sections from GluR2(B) AS-ODN-treated and
control ODN-treated animals to monitor eosinophilia and/or cell loss.
In rat pups infused with GluR2(B) AS-ODNs, Nissl-stained sections
showed specific neurodegeneration that was particularly notable in the
CA3a subregion and distant and lateral to the more medially placed
cannula infusion site (Fig.
3A-C). Cell loss and changes
in morphology of CA3 pyramidal neurons were detectable throughout the
rostrocaudal plane of the dorsal hippocampus. Subtle histopathological
changes were observed within CA3a neurons in more distant brain
sections posterior to the cannula infusion site. Hematoxylin/eosin
staining of nuclei revealed eosinophilic pyramidal CA3 neurons with
irregular shape, particularly around the CA3a bend subregion (Fig.
3C, F). Many surviving cells around the
lesion site appeared either basophilic and swollen or eosinophilic and
shrunken (see Fig. 8F). Small cells, probably glia,
surrounded the lesion, suggesting an acute reactive gliosis (Fig.
3F). In rat pups lacking phenotype, similar to
control S-ODN- or NS-ODN-infused pups, there was no obvious change in
morphology (see Fig. 9E). CA3b/c neurons near the cannula
infusion site were intact, with normal cytoarchitecture (Fig.
3D,E). CA3a lesions were apparent only in pups that exhibited continuous seizure-like behavior. Within
the contralateral hippocampus in all but one GluR2(B) AS-ODN-treated pup, morphology of pyramidal and granule cell types was
indistinguishable from control untreated sections. A subconvulsive dose
of KA was injected intraperitoneally into animals pretreated with
GluR2(B) AS-ODNs but lacking the phenotypic behavior. This resulted in CA3a cell loss that was more extensive and obvious compared with GluR2(B) AS-ODN pups exhibiting spontaneous behaviors, but CA1, hilus,
and DG remained spared (data not shown).

View larger version (117K):
[in this window]
[in a new window]
|
Figure 3.
Photomicrographs depicting GluR2(B)
knockdown-induced cell loss and morphological alterations in CA3
hippocampal neurons after 4 d of infusions. A,
Thionin-stained section from GluR2(B) AS-ODN-treated pup at low
magnification shows marked loss of CA3a pyramidal neurons (between
small arrows) just after the bend and posterior to the
level of infusion site (large arrow). B,
Loss of CA3a neurons by thionin is shown at higher magnification.
C, F, Hematoxylin/eosin-stained section
360 µm posterior to section displayed in B at low
(C) and high (F)
magnifications reveal eosinophilic neurons (large
arrows) and apparent glial cell proliferation (short
arrows) in posterior sections around the distant lesion.
D, NS-ODN control section at level of infusion site and
at low and high (E) magnifications shows that CA3
neurons distant from cannula infusion site are intact with normal
cytoarchitecture. Scale bar, 50 µm. i, Infusion site;
AS, antisense; NS, nonsense.
|
|
Normal fEPSP activity but loss of LTP in CA1 hippocampal slices
after GluR2(B) knockdown
After GluR2(B) knockdown, changes in synaptic function were
studied from the hippocampal CA1 subfield in slices prepared from GluR2(B) AS-ODN-treated pups versus control animals including (1) no
treatment, (2) S-ODN treatment, or (3) slices prepared from the
contralateral hemisphere. Although high-frequency rhythmical activity
was found in the EEG, epileptiform activity was not detectable in field
recordings in the presence or absence of seizure behavior, similar to
seizure phenotype GluR2(B) mutants with partial Q/R editing site
incompetence (Feldmeyer et al., 1999 ). There were no significant
differences between the antisense and control input/output characteristics of the slices, although knockdown slices tended to have
larger responses (measured as a slope of the fEPSP) for the same
stimulation intensity (Fig.
4B). Similar fEPSP
half-maximal baseline responses were evoked in GluR2(B) knockdown
slices and in the various types of control slices used (0.7667 ± 0.04975 mV, n = 8 and 0.7750 ± 0.0366 mV fEPSP
maximum, n = 12, for knockdown and control slices,
respectively; both values were not significantly different) (Fig.
4C,D). All slices also exhibited similar maximal fEPSP (1.6442 ± 0.1064 mV, n = 12 and 1.635 ± 0.07962 mV, n = 8, respectively).

View larger version (34K):
[in this window]
[in a new window]
|
Figure 4.
fEPSPs recorded from a single site in response to
alternately delivered stimuli to two separate inputs from control
versus experimental slices after GluR2(B) hippocampal knockdown.
A, Cross section showing stimulating (stim
1 and stim 2) and recording electrode
(rec) arrangements in respect to the infusion site
(asterisk). B, Averaged
input-stimulus/output-response relationship (input/output curve) in
GluR2(B) AS-ODN (circles) and control
(squares) slices. C, Field synaptic
responses in sense and antisense knockdown slices obtained before (1),
immediately after (2), and 13 min after (3) the high-frequency train of
stimuli. Note that the immediate post-tetanic trace from knockdown
slices reveals a population spike over the fEPSP. D,
Normalized fEPSP slope changes in GluR2(B) AS-ODN ( ) and control
( ) slices show impairment of tetanic LTP in CA1 averaged from both
sites; arrow indicates time of tetanus.
E, fEPSP recorded from a representative animal that did
not exhibit seizure behavior. First and second tetanic
stimulations (arrow) were delivered to inputs near ( )
and distal ( ) to the infusion site.
|
|
In contrast, in GluR2(B) knockdown slices prepared from pups that
exhibited seizure behavior, there was a population spike over the
maximal fEPSP in both stimulation pathways, suggesting that electrical
properties of the preparation were modified (data not shown). Identical
population spike activity over the fEPSP in GluR2(B) knockdown slices
occurred in the first post-tetanic trace after induction of tLTP with a
100 Hz, 1 sec tetanus (Fig. 4C). The amount of initial
post-tetanic potentiation in CA1 field recordings of knockdown and
control slices, averaged from both pathways, also did not reach
statistical significance (99.2 ± 15.9%, n = 12, and 113.7 ± 4.2%, n = 8, p = 0.08, respectively) (Fig. 4C,D). Interestingly,
slice preparations from animals with seizure behavior did not maintain
LTP whether stimulated near or distant from the infusion site,
suggesting that GluR2(B) knockdown increased excitability in medial and
distal regions of the hippocampus. Within 3 min potentiation, levels
dropped to near baseline values (7.8 ± 2.4%), whereas control
slices maintained LTP throughout the 30 min post-tetanic recording time
(60.9 ± 6.1%) (Fig. 4D). Differences in
two-channel recordings were observed in slices prepared from an animal
that did not exhibit seizure behavior (Fig. 4E).
Within 5 min potentiation, tLTP was markedly reduced when stimulations
were delivered close to the infusion site (13.6 ± 6.3%;
n = 4 slices) but maintained at near control levels
when stimulated from the distal site (56.7 ± 8.4%;
n = 4 slices).
Specificity of labeling by in situ hybridization
and immunohistochemistry
Because AS-ODNs can decrease expression of their target mRNA
attributable to binding of the oligo probes to the same sequence of the
endogenous mRNA, GluR2(B) and a more distantly related glutamate
receptor, NR1, mRNA expression were assessed by in situ hybridization autoradiography (Fig. 5)
and emulsion-dipping (Fig. 6). In
control sections, GluR2(B) and NR1 mRNA expression were prominent and
uniformly expressed throughout pyramidal and granule cell layers as
described previously (Nakanishi et al., 1992 ; Friedman et al., 1994 ,
1997a ,b ; Standley et al., 1995 ). After intrahippocampal infusion
of GluR2(B) AS-ODNs, in situ hybridization autoradiographs showed that GluR2(B) and NR1 mRNAs were unaltered throughout the surviving regions of the CA1, CA3, and DG hippocampal subfields in both
control and GluR2(B) AS-ODN-treated groups (CA1: 98 ± 5%; CA3:
91 ± 7%; DG: 97 ± 8%; vs control regions,
n = 3). In contrast, densitometric measurements (NIH
image) from the CA3 area of cell degeneration revealed an apparent
reduction in the expression of both GluR2(B) and NR1 mRNAs (to
49.2 ± 12%, n = 3, p < 0.05 vs
controls and 50 ± 2%, n = 2, respectively) (Fig. 5). However, light microscopy of emulsion-dipped sections
counterstained with hematoxylin/eosin confirmed that the decreases were
attributable to cell loss and that individual CA3a neurons expressed
control numbers of GluR2(B) and NR1 mRNA in situ
hybridization grains (GluR2 mRNA: 365 ± 16 vs 355 ± 12;
control vs GluR2(B) knockdown; and NR1 mRNA: 51 ± 3 versus
50 ± 4; control versus GluR2(B) knockdown). Therefore,
hippocampal mRNA levels within surviving CA3 neurons were not altered
by our AS-ODN infusion procedure.

View larger version (153K):
[in this window]
[in a new window]
|
Figure 5.
In situ hybridization showed that
GluR2(B) knockdown had no effect on the overall level of GluR2(B) or
NR1 mRNA expression. Loss of GluR2(B) expression was reduced only in
the area of lesion for GluR2(B) (A, B)
and for NR1 (C, D).
|
|

View larger version (155K):
[in this window]
[in a new window]
|
Figure 6.
Emulsion-dipped sections showed control levels of
GluR2(B) mRNA in individual neurons within the region of cell loss.
A, Control GluR2(B) mRNA (40×). B,
GluR2(B) mRNA after GluR2(B) knockdown. C, Control
GluR2(B) hybridization grains were dense and uniform, overlying
individual neurons (100×). D, At the single-cell level,
GluR2(B) mRNA in situ hybridization grains in GluR2(B)
knockdown sections were indistinguishable from control sections.
|
|
In contrast, AMPA receptor immunocytochemistry demonstrated specificity
for both oligonucleotide sequences used for selective antisense-induced
downregulation of GluR2(B) or GluR1(A) hippocampal proteins. In the
contralateral hippocampus and in control sections after S-ODN or NS-ODN
infusions, the pattern of cytoplasmic label of principal neurons for
GluR1(A) and GluR2(B) was dense and evenly distributed throughout the
hippocampus, as described previously (Rogers et al., 1991 ; Wenthold et
al., 1992 ; Vissavajjhala et al., 1996 ; Friedman et al., 1997a ,b ;
Friedman, 1998 ) (Figs. 7-9). After
GluR2(B) knockdown, the use of several available GluR2(B)-specific antibodies (mAb 3A11 GluR2(4) and mAb 6C4 provided by Dr. John Morrison
and the polyclonal mAb from Chemicon) and the polyclonal GluR1(A)
antibody (provided by Dr. Scott Rogers or purchased from Chemicon)
repeatedly showed that GluR2(B) but not GluR1(A) protein was
downregulated by the GluR2(B) AS-ODN infusion paradigm similar to our
previously reported Western blot data generated from adult rats
(Friedman and Velísková 1998 ) (Figs. 7-8). Within the
stratum lucidum, pyramidal cell dendrites lacked their typical diffuse and punctate immunolabeling patterns. Distal dendrites of many CA3
neurons were barely detectable near the lesion, although a few lightly
stained neurons could be seen (Fig.
8A,B).
The anatomical advantage of immunocytochemistry performed herein showed
not only that GluR2(B) immunolabel selectively declined throughout the ipsilateral hippocampus relative to the contralateral side or control
ODN-infused pups, but also that the greatest reductions were highly
apparent within CA2-CA3a-c subfields (Fig. 7B). However, intense downregulation of GluR2(B) protein was found regardless of
presence or location of hippocampal degeneration, indicating that loss
of the GluR2(B) subunit alone is insufficient to kill neurons. Neither
antibodies labeled areas containing many eosinophilic neurons (Fig.
8E,F), but GluR1(A)
immunoreactivity was abundant all around the lesioned area (Fig.
8C,D) after the GluR2(B) AS-ODN intrahippocampal
infusions. Therefore, a significant unilateral shift in the
GluR1(A)/GluR2(B) protein ratio appeared to be achieved by the
method used. Moreover, kainate-induced status epilepticus in
age-matched pups did not cause immunohistochemical downregulation of
the GluR2 subunit or damage (Fig.
9B), as reported previously by
us (Friedman et al., 1997a ,b ), so that seizure activity alone is
also not responsible for cell death. Similarly, some animals (n = 4) that did not exhibit seizure behavior after
GluR2(B) knockdown also did not have CA3a lesions, possibly because of
destruction of ventral blade granule cells by placement of the cannula
(Fig. 9E). Other pups infused with GluR2(B) AS-ODNs that did
not have spontaneous seizure behavior showed no obvious differences in cannula placement or damage produced by the infusions. In contrast, rat
pups that exhibited both spontaneous seizures and GluR2(B) downregulation had CA3a neurodegeneration after GluR2(B) knockdown (Fig. 3), suggesting that both seizures and loss of the GluR2(B) subunit are involved in the selective cell death.

View larger version (105K):
[in this window]
[in a new window]
|
Figure 7.
A, Photomicrograph showing that
GluR2(B) immunolabeling (6C4) of CA1-CA3 stratum pyramidale was dense
and uniform; GluR2(B) antibodies predominantly label soma, whereas
GluR1(A) antisera label soma and dendrites. A, In
sense-treated animal sections, GluR2(B) immunolabel was dense and
evenly distributed throughout the cytoplasm of CA3 neurons.
B, After GluR2(B) hippocampal knockdown (bold
arrowhead), GluR2(B) immunoreactivity was markedly reduced
throughout the CA2, CA3a-b, and part of CA3c subregions (between
arrows); CA1 and DG were downregulated but to a lesser
extent. C, GluR1(A) immunoreactivity after S-ODNs was
intense throughout the hippocampus. D, GluR1(A)
immunoreactivity was unchanged, suggesting that an increase in the
GluR1(A)/GluR2(B) protein was achieved by the GluR2(B) knockdown.
|
|

View larger version (98K):
[in this window]
[in a new window]
|
Figure 8.
Photomicrographs of GluR2(B) and
GluR1(A) immunolabeling of CA3 neurons after GluR2(B) knockdown at high
magnification (400×). A, In control GluR2(B)
sections, robust labeling of soma and proximal dendrites was
observed. B, CA3 neurons were particularly decreased in
GluR2(B) immunoreactivity; a few neurons were immunopositive near the
lesion (arrows). C, GluR1(A) control
immunoreactivity was dense and continuous with apical and basilar
dendrites. D, GluR1(A) immunoreactivity near the lesion
was unchanged. E, Control hematoxylin/eosin stain of CA3
just before the bend from contralateral hippocampus. F,
Shrunken nuclei and eosinophilia of CA3a neurons were detected by
hematoxylin/eosin stain (arrows). SR,
Stratum radiatum; SP, stratum pyramidale;
SO, stratum oriens.
|
|

View larger version (146K):
[in this window]
[in a new window]
|
Figure 9.
GluR1(A) knockdown decreases GluR1(A) but not
GluR2(B) immunoprotein without change in histology. A,
GluR1(A) S-ODN control microinfused pup (arrow).
B, After GluR1(A) hippocampal knockdown
(arrow), GluR1(A) immunoreactivity was markedly reduced
throughout the immature hippocampus. C, After
kainate-induced status epilepticus GluR2(B), immunoreactivity was
intense and unaltered throughout the hippocampus at this young age.
D, GluR2(B) immunoreactivity was unchanged, suggesting
that a decrease in the GluR1(A)/GluR2(B) protein was achieved.
E, No seizure control; thionin-stained section
after GluR2(B) knockdown without phenotypic behavior showed damage to
the ventral blade of the DG (n = 4).
F, GluR1(A) knockdown demonstrates intact morphology and
cytoarchitecture in adjacent Nissl-stained sections from the same rat
shown in B and D.
|
|
GluR1(A) hippocampal knockdown produced the opposite effect such that
GluR1(A) immunolabeling was markedly decreased and GluR2(B) immunolabeling in adjacent sections was unchanged (Fig. 9). GluR1(A) immunoreactivity was more evenly reduced throughout all hippocampal subfields of the ipsilateral hemisphere, with a slightly higher expression observed in CA3a neurons. There was no change in behavior or
hippocampal morphology (Fig. 9F), similar to a recent
report on genetically manipulated GluR1(A) knockout mice (Zamanillo et al., 1999 ). Thus, it appears that selective decreases in the GluR2(B) but not GluR1(A) subunit have functional and morphological consequences in the developing hippocampus. Several pups (n = 3)
coinjected with GluR1(A) and GluR2(B) AS-ODNS also did not exhibit
seizure behavior or damage, but because of a <50% success rate, many
more animals would need to be injected to determine whether loss of the
GluR1(A) subunit would prevent deleterious effects resulting from the
GluR2(B) AS-ODNs.
 |
DISCUSSION |
Our previous molecular studies show that KA-induced status
epilepticus has age-related consequences on gene expression, whereby AMPA and GABAA 1 subunits are decreased in
adult CA3 neurons destined to die (Friedman et al., 1994 ; Friedman,
1998 ) and are relatively unaltered in immature neurons resistant to
damage (Friedman et al., 1997a ). This article demonstrates that
a certain balance of GluR1(A) and GluR2(B) subunit expression within a
single hippocampus is needed to prevent epileptogenesis and
neurodegeneration in the developing brain.
Unexpectedly, we also recently reported that unilateral
GluR2(B) hippocampal knockdown does not acutely affect EEG activity in
adult rats or neonates during the first postnatal week (Friedman and
Velísková, 1998 ). Accordingly, reducing GluR2(B) (Brusa et al., 1995 ; Feldmeyer et al., 1999 ) but not GluR1(A) (Zamanillo et
al., 1999 ) receptor expression and function by genetic
strategies results in age-dependent seizures. This
sensitive period coincides with a stage in development when constituent
GluR1(A) and GluR2(B) mRNA levels are high (Moyner et al., 1991 ;
Standley et al., 1995 ) and may be a molecular mechanism to prevent
epileptogenesis at a certain age. Lowering extracellular
Ca2+ levels in young animals also can
induce spontaneous paroxysmal activity (Albrecht and Heinemann, 1989 ).
Our data suggest that intracellular Ca2+
levels increase because of a shift in the GluR1(A)/GluR2(B) protein ratio induced by the GluR2(B) knockdown procedure and may partially lead to the observed alterations in behavior, EEG, and LTP patterns. We
have supportive evidence that GluR2(B) AS-ODN exposure to dissociated hippocampal neurons also increases the GluR1(A)/GluR2(B) protein ratio
and leads to pharmacologically selective increases in AMPA-mediated Ca2+ influx as determined by dye imaging
with fura-2 AM (Friedman et al., 1997b ). However, it is also
possible that reduction of AMPA receptor GluR2(B) subunit levels may
increase single-channel conductance of AMPA receptors, which in turn
could lead to hyperexcitability within hippocampal circuits and be
responsible for the population spike observed after tetanic
stimulation. Changes in AMPA-mediated Ca2+
permeability or single-channel conductance would occur presumably via
increased formation of GluR1(A) heteromeric assemblies with GluR3(C) or
GluR4(D) subunits or by GluR1(A) homomers. In contrast, selective
downregulation of the hippocampal GluR1(A) subunit did not affect
behavior or morphology, further supporting the possibility that the
presence of the GluR1(A) subunit is needed to mediate the deleterious
effects produced by the GluR2(B) knockdown procedure.
Specificity of the antisense infusions by in situ
hybridization analyses showed that GluR2(B) mRNA was not significantly
decreased as predicted by the procedure, although antisense-induced
decreases in mRNA have been reported (for review, see Loose-Mitchell,
1988 ; Uhlmann and Peyman, 1990 ). Control expression of GluR2(B) mRNA after GluR2(B) knockdown in our study is a result of detecting the
endogenous mRNA with full-length cRNA probes that bind to a much longer
sequence than the AS-ODNs used. Consistent with previous histochemical
findings (Friedman and Velísková, 1998 ), there was
pronounced cell loss in the distant CA3a subregion, with discrete
damage along the rostrocaudal plane and little cytotoxicity near the
site of infusion. However, here and previously (Friedman and
Velísková, 1998 ) we have shown compelling data in adult rats that downregulation alone of the GluR2(B) subunit is insufficient to induce neurodegeneration in the knockdown model, which is also in
agreement with several surviving GluR2(B) editing-deficient phenotypes
(Kask et al., 1998 ; Feldmeyer et al., 1999 ), GluR2(B) knockout mice
(Jia et al., 1996 ), and ischemia-resistant interneurons (Catani
et al., 1995 ). 33P autoradiography
demonstrated that the diffusion of ODNs to all regions of the
hippocampus, therefore sparing of the CA1 and DG regions, was not
caused by lack of uptake. Radiolabeled accumulations of the GluR2(B)
ODNs were highest in the CA3 and may explain why depletion of GluR2(B)
protein and damage were greatest in this region. Moreover, GluR1(A)
knockdown did not alter behavior or cell survival, further supporting
the possibility that the level of the GluR2(B) subunit within a single
hippocampus may be an important limiting factor in age-dependent epileptogenesis.
Rat pups exhibiting no seizure behavior or only scratching automatisms
did not display CA3 damage, possibly because of individual differences
in (1) cannula placement, (2) amount of ODN delivered and accumulated,
or (3) extent of GluR2(B) downregulation. It should be noted, however,
that there were differences in the pattern of CA3 cell loss in pups
after GluR2(B) knockdown when compared with the classical damage
described after KA-induced status epilepticus in adults. Hippocampal
neurodegeneration in our knockdown pups was mostly restricted to the
CA3a subregion in or after the bend, despite the large decreases in
GluR2(B) protein observed in the injected hippocampus that caused
qualitative decreases in immunoreactivity throughout all areas of the
CA3a-c. The dramatic loss of GluR2(B) immunolabeling within dendrites
near the associated lesion and sustained GluR1(A) immunolabel is
unlikely to be attributable to an artifact of the particular antibody
used because three specific GluR2(B) antibodies revealed the same
effects, suggesting that dendritic turnover of the GluR2(B) subunit may
be less efficient relative to the soma. Similar alterations in the
GluR1(A)/GluR2(B) ratio were observed in cultured single hippocampal
neurons exposed to the GluR2(B) AS-ODNs (our unpublished
observations). Hilar interneurons appeared mostly unaffected by
the antisense-induced downregulation of hippocampal GluR2(B) protein,
whereas these neurons are highly vulnerable to seizure-induced damage
in adults in a number of seizure models (Nadler, 1981 ; Ben-Ari,
1985 ; Sperk 1994 ). A reduction in seizure threshold is supported by the
following observations: (1) behavioral manifestations in young rats
produced by the GluR2(B) AS-ODNs correspond to high-frequency
paroxysmal activity in the EEG; (2) a subconvulsive dose of KA produced
high-rhythmical oscillations and behavioral status epilepticus in
GluR2(B) AS-ODN-pretreated pups lacking the phenotypic behavior; (3)
high-rhythmical activity was not detected in control infused animals;
(4) field recordings in ex vivo slices showed rapid onset of
population spikes to high-intensity stimulation only in animals that
were recipient to the GluR2(B) hippocampal knockdown treatment; and (5)
GluR1(A) unilateral hippocampal knockdown did not result in seizures or
damage. Combined data suggest that certain levels of glutamate,
overexpression of Ca2+-permeable AMPA
receptor channels, changes in single-channel conductance properties, or
postsynaptic activity of mossy fibers together may be necessary to
induce the selective CA3 cell loss. It appears that a particular amount
of GluR2(B) expression must be lost in both antisense and genetic
models before sufficient changes in synaptic activity occur within the
hippocampal network and that neuronal populations affected within the
deprived GluR2(B) circuit to regulate the activity may arise from the
CA3. Recent studies of Feldmeyer et al. (1999) prove that induction of
an age-dependent seizure-prone mutant phenotype is negatively
correlated with the level of editing-efficient GluR2(B) gene expression.
Conventional tetanus-induced LTP in CA1 (a long-lasting increase in
synaptic transmission efficacy) is dependent on the activation of NMDA
receptors and a rise in intracellular calcium concentration (Bliss and
Lomo 1973 ; Auerbach and Segal, 1997a ). LTP is complex in that
it can also be induced by means other than tetanic stimulation and has
been shown to be dependent on or independent of NMDA receptor activation (Auerbach and Segal, 1994 , 1997b ; Cavus and Teyler, 1996 ).
After in vivo GluR2(B) knockdown, induction of LTP was unaltered, as was NR1 expression, suggesting that hippocampal NMDA
receptors were operational after the antisense infusions. However, LTP
responses dropped off rapidly in GluR2(B) knockdown slices from animals
with seizure behavior, suggesting that the stimulus train induced a
transient increase in the fEPSPs, similar to the short-term
potentiation (STP) observed when subthreshold tetani are applied
(Malenka and Nicoll, 1993 ; Aniksztejn and Ben-Ari, 1995 ). This
STP was associated with population spikes highly similar to our
observations, suggesting increased excitability of the dendrites
possibly by rises in Ca2+ that appear to
be supported by the higher CA1 responses recorded from GluR2(B)
knockdown slices. In an animal without altered behavior, tLTP was
impaired near the infusion site, but normal tLTP was recorded when
stimulation was delivered to the distal site, suggesting that changes
in the electrical properties of the circuit did not spread to distal
regions. A deprived circuit of the GluR2(B) subunit in both medial and
lateral regions of the immature hippocampus may be responsible for
epileptogenesis, possibly by causing an increased transfer of currents
from the fEPSP generated in dendrites to increase their excitability
and the spike-generating mechanisms of the cell body region.
In contrast to our observations, slices prepared from GluR2(B) knockout
mice without seizure phenotype had enhanced LTP (Jia et al., 1996 ) and
partial editing-incompetent GluR2(B) mutants with seizure
phenotype-expressed LTP similar to wild type when NMDA receptor
antagonist APV was not applied (Feldmeyer et al., 1999 ). It is
likely that differences in developmental compensatory mechanisms exist
in the various GluR2(B) mutant genotypes compared with our acute model
of GluR2(B) knockdown to explain the different effects on tLTP.
However, we also expect that differences exist because of the various
tetanic stimulation characteristics used. For example, induction of
tLTP in GluR2(B) editing-incompetent mutants (Feldmeyer et al., 1999 )
was achieved by using a different stimulation paradigm than ours
(20-90 µsec, 0.2 Hz vs 50 µsec, 0.033 Hz stimulations,
respectively) and required a higher stimulus intensity. In addition,
our antisense model is not only less compensated because of its acute
nature but also because reductions in GluR2(B) were restricted to a
single hippocampus rather than the entire brain. Consistent with our
observations, slices prepared from seizure-phenotype GluR2(B) mutants
(1) did not exhibit spontaneous epileptiform activity, and (2) certain
genotypes presented increased number of failures to induce LTP or they
required 30% higher stimulus intensity compared with other genotypes.
An alternative explanation as to why we lose LTP in CA1 of our GluR2(B)
knockdown slices may be an induced overexcitability attributable to an
acute saturation of intracellular Ca2+
levels within the hippocampus, particularly in CA3, altered
Na+ conductance, and lack of GluR2(B)
assembly with the GluR1(A) subunit at mossy fiber and Schaffer
collateral synapses. GluR1(A) gene knockouts, completely lacking LTP,
exhibit marked reduction in translocation of GluR2(B) subunits into
dendrites, probably because of their inability to assemble with GluR(A)
subunits (Zamanillo et al., 1999 ). In fact, the presence of the
GluR2(B) subunit facilitates assembly of AMPA receptors (Wenthold et
al., 1996 ). Further pharmacological analysis is in progress to
define the role of glutamate receptor types in our knockdown model by
antagonist application and the effects of reduced GluR2(B) expression
on LTD.
In conclusion, unilateral hippocampal GluR2(B) knockdown may provide a
powerful strategy for studying the roles of certain receptor subunits
in young rat pups that are highly prone to seizures but relatively
resistant to damage. It appears that the GluR2(B) subunit is needed for
normal development of hippocampal plasticity and CA3 neuronal survival
at a time when the brain is undergoing major changes in CNS inhibitory
and excitatory amino acid function. Our study supports the importance
of examining various AS-ODNs and AMPA receptor
Ca2+ blockers or antagonists as
neuroprotective agents in epilepsy at several ages. Although why CA3a
pyramidal neurons are particularly vulnerable to cell death after
GluR2(B) knockdown remains to be elucidated, chronic unilateral
downregulation of the GluR2(B) hippocampal subunit by in
vivo infusion of GluR2(B) AS-ODNs may provide a novel partial
seizure model in the developing rat.
 |
FOOTNOTES |
Received June 16,1999; revised Aug. 4, 1999; accepted Aug. 23, 1999.
This work was supported by March of Dimes and National Institutes of
Health Grant NS-38069 (L.K.F.), and a Sir Charles Clore Fellowship
(A.R.K.). We are indebted to Dr. Jana Velísková, Dr.
Solomon L. Moshé, Dr. Menachem Segal, and Dr. Yehezkel Ben-Ari for their invaluable comments and for providing necessary space to
carry out experiments. We thank Bonaventure Magrys for technical assistance with GluR1(A) immunocytochemical studies and Mr. Howard Rubin and the Graphic Arts Center at Albert Einstein College of Medicine for expert photography.
Correspondence should be addressed to Dr. Linda K. Friedman, Department
of Neuroscience, Seton Hall University, 400 South Orange Avenue, South
Orange, NJ 07079. E-mail: lfriedma{at}aol.com.
 |
REFERENCES |
-
Albala BJ,
Moshé SL,
Okada R
(1984)
Kainic-acid-induced seizures: a developmental study.
Dev Brain Res
13:139-148.
-
Aniksztejn L,
Ben-Ari Y
(1995)
Expression of LTP by AMPA and/or NMDA receptors is determined by the extent of NMDA receptors activation during the tetanus.
J Neurophysiol
74:2349-2357[Abstract/Free Full Text].
-
Auerbach J,
Segal M
(1994)
A novel cholinergic induction of long term potentiation in rat hippocampus.
J Neurophysiol
72:2034-2040[Abstract/Free Full Text].
-
Auerbach J,
Segal M
(1997a)
Peroxide modulation of slow onset potentiation in rat hippocampus.
J Neurosci
17:8695-8701[Abstract/Free Full Text].
-
Auerbach J,
Segal M
(1997b)
Muscarinic receptors involved in hippocampal plasticity.
Life Sci
60:1085-1091[Web of Science][Medline].
-
Albrecht D,
Heinemann U
(1989)
Low calcium-induced epileptiform activity in hippocampus slices from infant rats.
Dev Brain Res
48:316-320[Medline].
-
Babb TL,
Brown WJ
(1987)
Pathological findings in epilepsy.
In: Surgical treatment of the epilepsies (Engel Jr J,
ed), pp 511-540. New York: Raven.
-
Ben-Ari Y
(1985)
Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy.
Neuroscience
14:375-403[Web of Science][Medline].
-
Bliss T,
Lomo T
(1973)
Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path.
J Physiol (Lond)
232:331-356[Abstract/Free Full Text].
-
Brusa RF,
Zimmermann,
Koh D-S,
Feldmeyer D,
Gass P,
Seeburg PH,
Sprengel R
(1995)
Early onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice.
Science
270:1677-1680[Abstract/Free Full Text].
-
Bruton CJ
(1988)
In: The neuropathology of human temporal lobe epilepsy. New York: Oxford UP.
-
Burnashev N,
Monyer H,
Seeburg PH,
Sakmann B
(1992)
Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit.
Neuron
8:189-198[Web of Science][Medline].
-
Catani MV,
Tolle TR,
Monyer H
(1995)
Differential expression of AMPA receptor subunits in NOS-positive neurons of cortex, striatum, and hippocampus.
J Neurosci
15:7046-7061[Abstract].
-
Cavus I,
Teyler T
(1996)
Two forms of long-term potentiation in area CA1 activate different signal transduction cascades.
J Neurophysiol
76:3038-3047[Abstract/Free Full Text].
-
Charriaut-Marlangue C,
Aggoun-Zouaoui D,
Repressa A,
Ben-Ari Y
(1996)
Apoptotic features of selective neuronal death in ischemia, epilepsy, and gp 120 toxicity.
Trends Neurosci
19:109-114[Web of Science][Medline].
-
Cherubini E,
De Feo MR,
Mecarelli O,
Ricci GF
(1983)
Behavioral and electrographic patterns induced by systemic administration of kainic acid in developing rats.
Dev Brain Res
9:69-77.
-
Choi D
(1990)
Glutamate neurotoxicity and diseases of the nervous system.
Neuron
1:623-634.
-
DeFelipe J,
Huntly GW,
del Rio MR,
Sola RG
(1994)
Microzonal decreases in the immunostaining for non-NMDA ionotropic excitatory amino acid receptor subunits GluR2(B)/3 and GluR5/6/7 in the human epileptogenic neocortex.
Brain Res
657:150-158[Web of Science][Medline].
-
Dingledine R,
McBain CJ,
McNamara JO
(1990)
Excitatory amino acid receptors in epilepsy.
Trends Pharmacol
11:334-338[Medline].
-
Feldmeyer D,
Kask K,
Brusa R,
Kornau HC,
Kolhekar R,
Burnashev N,
Jensen V,
Hvalby O,
Sprengel R,
Seeburg PH
(1999)
Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B.
Nat Neurosci
2:57-64.[Web of Science][Medline]
-
Friedman LK
(1998)
Selective reduction of GluR2(B) protein in adult hippocampal CA3 neurons following status epilepticus but prior to cell loss.
Hippocampus
8:511-525[Web of Science][Medline].
-
Friedman LK,
Velísková J
(1998)
GluR2(B) hippocampal knockdown reveals developmental regulation of epileptogenicity and neurodegeneration.
Mol Brain Res
61:224-231[Medline].
-
Friedman LK,
Pellegrini-Giampietro DE,
Sperber EF,
Bennett MVL,
Moshé SL,
Zukin RS
(1994)
Kainate-induced status epilepticus alters glutamate and GABAA receptor gene expression in adult rat hippocampus: an in situ hybridization study.
J Neurosci
14:2697-2707[Abstract].
-
Friedman LK,
Sperber EF,
Moshé SL,
Bennett MVL,
Zukin RS
(1997a)
Developmental regulation of glutamate and GABAA receptor gene expression in rat hippocampus following kainate-induced status epilepticus.
Dev Neurosci
19:529-542[Medline].
-
Friedman LK,
Velísková J,
Spray DC,
Segal M
(1997b)
GluR2 hippocampal knockdown enhances and accelerates kainate seizure-induced damage in adult rats and increases Ca2+ permeability in primary culture.
In: ISN/ASN Satellite Symposium and Aspet Colloqium on Excitatory Amino Acids.
-
Hollman M,
Hartley M,
Heinemann S
(1991)
Ca2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition.
Science
253:1028-1031[Abstract/Free Full Text].
-
Holmes GL,
Thompson JL
(1988)
Effects of kainic acid on seizure susceptibility in the developing brain.
Dev Brain Res
39:51-59.
-
Jia Z,
Nadia A,
Miu P,
Xiong Z,
Henderson J,
Geriai R,
Taverna FA,
Velumian A,
Mac Donald J,
Carlen P,
Abrominov-Newerly W,
Roder J
(1996)
Enhanced LTP in mice deficient in the AMPA receptor GluR2(B).
Neuron
17:945-956[Web of Science][Medline].
-
Kask K,
Zamanillo D,
Burnashev N,
Sprengel R,
Seeburg PH
(1998)
The AMPA receptor subunit GluR-B in its Q/R site-unedited form is not essential for brain development and function.
Proc Natl Acad Sci USA
95:13777-13782[Abstract/Free Full Text].
-
Keinänen K,
Wisden W,
Sommer B,
Werner P,
Herb A,
Verdoorn TA,
Sakmann B,
Seeburg P
(1990)
A family of AMPA-selective glutamate receptors.
Science
249:556-560[Abstract/Free Full Text].
-
Koudinov AR,
Groner Y,
Segal M
(1998)
Cu/Zn-SOD transgenic mice are impaired in slow onset, long term potentiation.
Neurosci Lett
51:S23.
-
Loose-Mitchell DS
(1988)
Antisense nucleic acids as a potential class of pharmaceutical agents.
Trends Pharmacol
9:45-47[Medline].
-
Lynd-Balta E,
Pilcher WH,
Joseph SA
(1996)
Distribution of AMPA receptor subunits in the hippocampal formation of temporal lobe epilepsy patients.
Neuroscience
72:15-29[Medline].
-
Malenka RC,
Nicoll RA
(1993)
NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms.
Trends Neurosci
16:521-527[Web of Science][Medline].
-
Mathern GW,
Pretorious JK,
Kornblum HI,
Mendoza D,
Lozada A,
Leite MF,
Adelson D,
Peacock WJ
(1998)
Human hippocampal AMPA and NMDA mRNA levels in temporal lobe epilepsy patients.
Brain
120:101-105.
-
Monyer H,
Seeburg PH,
Wisden W
(1991)
Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing.
Neuron
6:799-810[Web of Science][Medline].
-
Nadler JV
(1981)
Kainic acid as a tool for the study of temporal lobe epilepsy.
Life Sci
29:31-42.
-
Nakanishi N,
Axel R,
Schneider NA
(1992)
Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors.
Proc Natl Acad Sci USA
89:8552-8556[Abstract/Free Full Text].
-
Nitecka LE,
Tremblay G,
Charton Bouillot JP,
Berger ML,
Ben-Ari Y
(1984)
Maturation of kainic acid seizure brain damage syndrome in the rat. II. Histopathological sequelae.
Neuroscience
13:1073-1094[Web of Science][Medline].
-
Paxinos G,
Watson C
(1986)
In: The rat brain in stereotaxic coordinates, Ed 2. Sydney: Academic.
-
Pollard H,
Moreau HJ,
Ben-Ari Y,
Khrestchatisky M
(1993)
Alterations of the GluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia.
Neuroscience
57:545-554[Web of Science][Medline].
-
Prince HK,
Conn PJ,
Blackstone CD,
Huganir RL,
Levey AI
(1995)
Down-regulation of AMPA receptor subunit GluR2(B) in amygdaloid kindling.
J Neurochem
64:462-465[Web of Science][Medline].
-
Rogers SW,
Hughes TE,
Hollmann M,
Gasic GP,
Deneris ES,
Heinemann S
(1991)
The characterization and localization of the glutamate receptor subunit GluR1(A) in the rat brain.
J Neurosci
11:2713-2724[Abstract].
-
Schreiber SS,
Baudry M
(1995)
Selective neuronal vulnerability in the hippocampus: a role for gene expression?
Trends Neurosci
18:446-450[Web of Science][Medline].
-
Siesjo BK,
Bengtsson F
(1989)
Ca2+ fluxes, Ca2+ antagonists, and Ca2+-mediated pathology in brain ischemia, hypoglycemia, and spreading depression.
J Cereb Blood Flow Metab
9:127-140[Web of Science][Medline].
-
Sommer B,
Keinänen K,
Verdoon TA,
Wisden W,
Burnashev N,
Herb A,
Kohler M,
Takagi T,
Sakmann B,
Seeburg PH
(1990)
Flip and flop: a cell specific functional switch in operated channels of the CNS.
Science
249:1580-1585[Abstract/Free Full Text].
-
Sperk G
(1994)
Kainic acid seizures in the rat.
Prog Neurobiol
42:1-32[Web of Science][Medline].
-
Standley S,
Tocco G,
Tourigny MF,
Massicotte G,
Thompson RF,
Baudry M
(1995)
Developmental changes in
-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor properties and expression in the rat hippocampal formation.
Neuroscience
67:881-892[Web of Science][Medline]. -
Tremblay E,
Nitecka L,
Berger ML,
Ben-Ari Y
(1984)
Maturation of kainic acid seizure-brain damage syndrome in the rat: clinical, electrographic and metabolic observations.
Neuroscience
13:1051-1072[Web of Science][Medline].
-
Uhlmann E,
Peyman A
(1990)
Antisense oligonucleotides: a new therapeutic principle.
Chem Rev
90:544-584.
-
Verdoorn TA,
Burnashev N,
Monyer H,
Seeburg PH,
Sakmann B
(1991)
Structural determinants of ion flow through recombinant glutamate receptor channels.
Science
252:1715-1718[Abstract/Free Full Text].
-
Vissavajjhala P,
Janssen WGM,
Hu Y,
Gazzaley AH,
Moran T,
Hof PR,
Morrison JH
(1996)
Synaptic distribution of the AMPA-GluR2(B) subunit and its colocalization with calcium-binding proteins in rat and cerebral cortex: an immunohistochemical study using a GluR2-specific monoclonal antibody.
Exp Neurol
142:295-311.
-
Wenthold RJ,
Yokotani N,
Doi K,
Wada K
(1992)
Immunochemical characterization of the non-NMDA glutamate receptor using subunit specific antibodies: evidence for a hetero-oligomeric structure in rat brain.
J Biol Chem
267:501-507[Abstract/Free Full Text].
-
Wenthold RJ,
Petralia RS,
Blahos II J,
Niedzielski AS
(1996)
Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons.
J Neurosci
16:1982-1989[Abstract/Free Full Text].
-
Wonziak DF,
Stewart GR,
Miller P,
Olney JW
(1991)
Age-related sensitivity to kainate neurotoxicity.
Exp Neurol
114:250-253[Medline].
-
Zamanillo D,
Sprengel R,
Hvalby Ø,
Jensen V,
Burnashev N,
Rozov A,
Kaiser KM,
Käster HJ,
Borchardt T,
Worley P,
L
bke J,
Frotscher M,
Kelly PH,
Sommer B,
Anderson P,
Seeburg PH,
Sakmann B
(1999)
Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning.
Science
284:1805-1810[Abstract/Free Full Text].
Copyright © 1999 Society for Neuroscience 0270-6474/99/19219412-14$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
L. K. Friedman
CALCIUM: A Role for Neuroprotection and Sustained Adaptation
Mol. Interv.,
December 1, 2006;
6(6):
315 - 329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Shimshek, V. Jensen, T. Celikel, Y. Geng, B. Schupp, T. Bus, V. Mack, V. Marx, O. Hvalby, P. H. Seeburg, et al.
Forebrain-Specific Glutamate Receptor B Deletion Impairs Spatial Memory But Not Hippocampal Field Long-Term Potentiation.
J. Neurosci.,
August 15, 2006;
26(33):
8428 - 8440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Li and D. A. Prince
Synaptic Activity in Chronically Injured, Epileptogenic Sensory-Motor Neocortex
J Neurophysiol,
July 1, 2002;
88(1):
2 - 12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Sanchez, S. Koh, C. Rio, C. Wang, E. D. Lamperti, D. Sharma, G. Corfas, and F. E. Jensen
Decreased Glutamate Receptor 2 Expression and Enhanced Epileptogenesis in Immature Rat Hippocampus after Perinatal Hypoxia-Induced Seizures
J. Neurosci.,
October 15, 2001;
21(20):
8154 - 8163.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|